Inactive Instrument

Insiders Theseus Pharmaceuticals, Inc.

Equities

Theseus Pharmaceuticals, Inc. Announces Board Resignations	Feb. 14	CI
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023	Dec. 04	CI
Theseus Pharmaceuticals, Inc. Announces Management Changes	Dec. 04	CI
Insider Buy: Theseus Pharmaceuticals	23-07-19	MT
Insider Buy: Theseus Pharmaceuticals	22-11-09	MT
Theseus Pharmaceuticals, Inc. Appoints Steven Stein to Board of Directors	22-10-19	CI
Theseus Pharmaceuticals Names THE-349 as Development Candidate to Treat Lung Cancer	22-10-03	MT
Theseus Pharmaceuticals, Inc. Nominates The-349, A Fourth-Generation EGFR Inhibitor Development Candidate in Non-Small Cell Lung Cancer	22-10-03	CI
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors	22-05-18	CI
Insider Buy: Theseus Pharmaceuticals	22-01-24	MT
Theseus Pharmaceuticals, Inc. Appoints Alicja Januszewicz as Senior Vice President, People and Culture	21-12-16	CI
Theseus Pharmaceuticals, Inc. Announces Management Appointments	21-11-15	CI
Insider Buy: Theseus Pharmaceuticals	21-10-14	MT

No results for this search